These results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the thought of targeting ACKR3 as a unique way to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Problems. These success propose that conolidine https://hughq358ohz3.wikistatement.com/user